Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine and Ketoconazole Formulation

NCT01615913 is registered in ClinicalTrials.gov with Taiwan Biotech Co., Ltd. as lead sponsor.

NCT NCT01615913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01615913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine and Ketoconazole Formulation
Lead sponsor
Taiwan Biotech Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2012
Completion date
June 30, 2013
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis